AREAS OF APPLICATION
Disinfection and Sterlization of Injectibles, Formulations, CIP, Storage Tanks and Piplelines
"A Swiss Eco-friendly, Chlorine-free Disinfectant and Fumigant"
Your solution for a sterile environment.
Virosil Pharma is a revolutionary, eco-friendly, non-toxic disinfectant and fumigant for use in Pharmaceutical companies, Life Science Institutes, Research Labs and Hospital Operation Theatres.
The patented formulation of Virosil Pharma forms a complex compound which kills all forms of bacteria, viruses, spores including Staphylococcus aureus, Aspergillus niger, Salmonella, Pseudomonas, MRSA & H5N1 virus.
Virosil Pharma is a clear, colourless, odourless, tasteless liquid disinfectant which is non-carcinogenic, non-mutagenic, non toxic and can be used where other chlorine based disinfectants are ineffective for use.
The formulation has been thoroughly tested in Western Europe, Australia, the Middle East and India and also approved by the US Food and Drug Administration (FDA).
The added benefits of Virosil Pharma are that it does not have a foul odor, no irritation to the eyes, requires no de-fumigation and is very easy to handle. There are also no fears of overdosing and no residual effects. A room of 1,000 cubic feet can be rendered completely sterile in 60 minutes using a 20% of solution of Virosil Pharma.
We recommend use with a ULV fogger which produces a very fine mist and allows our product to be suspended in the atmosphere for a longer period of time allowing for penetration between cracks of surfaces ensuring a safe and sterile environment.
Virosil Pharma is also very widely used for disinfection pipelines and storage tanks as it is the most effective disinfectant on Biofilms. Other applications include disinfection of surfaces and instruments, hand sanitization and raw water disinfection.
Injectables, Formulations, Production, Packaging & Filling Areas, R&D Laboratories, Tissue Culture labs, QC & QA Laboratories - all benefit from the use of Virosil Pharma in the following applications:
Virosil Pharma has been the ideal choice of the users for replacing Formalin Formaldehyde Fumigation. Concentration: 20%
(for 1000 cu. ft. area to be fumigated with ULV fogger - i.e. 200 ml of Virosil Pharma in 800 ml DM water to be sprayed for 30 min).
Contact Time: One hour, after which the area will be sterile
Apply 10% solution of Virosil Pharma on floors, walls, tables and linen
Dip the instruments in a 10% solution
CIP/Loop System Disinfection
When used in recommended dosages it completely eliminates Biofilms
Resin and Filter Disinfection
Dip in a 1% to 3% solution to control foul odour & contamination
Storage Tank Disinfection
Spray the surfaces of the tank with 5% solution
Wash with 10% solution
Apply as per recommendation
Test Reports from Reputed Institutes
Virosil Pharma has been tested by several leading Institutions in India with for its disinfection and fumigation properies in the pharmaceutical manufacture and healthcare industry.
Some of the Institutions where extensive tests and trials are conducted on Virosil Pharma's applications.
- Haffkine's Institute of India: Efficacy test against various micro-organisms.
- Indian Drugs Research Laboratory, Pune: Toxicity Report
- Italab Pvt. Ltd.: Surface Disinfection
- KEM Hospital Infection Committee: Study on efficacy against various pathogens
- State Public Health Laboratory: Report on bacteriological examination of Water
- Reports from Mircochem Laboratories on Air, Surface and Water disinfection
- Reports of the Fumigation Trials carried out at: Astra IDL,
- Serum Institute of India, Nicholas Piramal, Medlar Labs (Cipla)
- Manisha Analytical laboratory : Toxicity Report
Pharmaceutical customers successfully using Virosil Pharma's eco-friendly formulation:
- Sun Pharmaceutical Laboratories Ltd.
- Aurobindo Pharma Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Serum Institute of India Ltd
- Lupin Ltd.
- Torrent Gujarat Biotech Pvt Ltd.
- Wochhardt Ltd.
- Unichem Laboratories
- Mylan Labs
- Biocon Ltd.
- Johnson & Johnson
- Piramal Healthcare
- Dabur India Ltd.
- Cipla Ltd.